Sylvia Duin
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Recurrence in High-grade Vulvar Intraepithelial Neoplasia: A Comprehensive Cohort Analysis.
Journal: Journal of lower genital tract disease
Published: January 22, 2026
Diagnostic Performance of the ASCL1/ZNF582 Methylation Test for Detection of High-Grade Vulvar Intraepithelial Neoplasia and Vulvar Cancer.
Journal: Molecular diagnosis & therapy
Published: November 11, 2025
DNA methylation and copy number alterations in the progression of HPV-associated high-grade vulvar intraepithelial lesion.
Journal: International journal of cancer
Published: August 14, 2024
DNA methylation testing for vulvar cancer risk stratification in patients with high-grade vulvar intraepithelial neoplasia: a population-based cohort study.
Journal: The British journal of dermatology
Published: March 28, 2024
DNA Methylation and p53 Immunohistochemistry as Prognostic Biomarkers for Vulvar Lichen Sclerosus.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: December 01, 2023
Clinical validation of methylation biomarkers for optimal detection of high-grade vulvar intraepithelial neoplasia.
Journal: International journal of cancer
Published: November 08, 2022
Validation of ASCL1 and LHX8 Methylation Analysis as Primary Cervical Cancer Screening Strategy in South African Women with Human Immunodeficiency Virus.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: June 26, 2022
Prognostic value of proliferation, PD-L1 and nuclear size in patients with superior sulcus tumours treated with chemoradiotherapy and surgery.
Journal: Journal of clinical pathology
Published: March 23, 2021
DNA methylation markers for cancer risk prediction of vulvar intraepithelial neoplasia.
Journal: International journal of cancer
Published: September 25, 2020
Influence of preanalytical variables on performance of delta-like protein 3 (DLL3) predictive immunohistochemistry.
Journal: Virchows Archiv : an international journal of pathology
Published: April 08, 2020
ALK immunohistochemistry positive, FISH negative NSCLC is infrequent, but associated with impaired survival following treatment with crizotinib.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: July 18, 2019
Last Updated: 09/26/2026